Texas Capital Bank Wealth Management Services Inc
BankPosition in INAB — In8bio, Inc.
CIK 1802655
Dallas, TX
Position in INAB
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$34,412
-$738 QoQ
Shares Held
24,406
+2.8% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 21 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Texas Capital Bank Wealth Management Services Inc holds $2,619,615 across 9 Biotechnology names. INAB ranks #9 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CUE |
Cue Biopharma, Inc.
|
22,881 | $722,124 | |
| 2 | IRD |
Opus Genetics, Inc.
|
122,529 | $503,594 | |
| 3 | RNTX |
Rein Therapeutics, Inc.
|
300,758 | $312,787 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
3,527 | $306,672 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
429 | $213,097 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
329 | $205,144 | |
| 7 | CGTX |
Cognition Therapeutics Inc
|
143,296 | $164,790 | |
| 8 | ACTU |
Actuate Therapeutics, Inc.
|
102,612 | $156,995 |
All Filings in INAB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,412 | 24,406 | Shares | Other | 2026-08-07 | |
| 2026-03-31 | $35,150 | 23,750 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $55,575 | 23,750 | Shares | Other | 2026-02-09 | |
| 2024-09-30 | $21,228 | 78,624 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $66,594 | 78,624 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $92,776 | 78,624 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $108,501 | 78,624 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $44,142 | 42,445 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||